Literature DB >> 11263790

Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma.

M Kubo1, H Ihn, K Yamane, K Tamaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11263790     DOI： 10.1002/1529-0131(200103)44:3<731::AID-ANR124>3.0.CO;2-U

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  17 in total

1.  Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masahide Kubo; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

2.  Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-β1 signaling.

Authors:  Chun Geun Lee; Erica L Herzog; Farida Ahangari; Yang Zhou; Mridu Gulati; Chang-Min Lee; Xueyan Peng; Carol Feghali-Bostwick; Sergio A Jimenez; John Varga; Jack A Elias
Journal:  J Immunol       Date:  2012-07-23       Impact factor: 5.422

Review 3.  Scleroderma, fibroblasts, signaling, and excessive extracellular matrix.

Authors:  Hironobu Ihn
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

Review 4.  Systemic and localized scleroderma in children: current and future treatment options.

Authors:  Margalit E Rosenkranz; Lucila M A Agle; Petros Efthimiou; Thomas J A Lehman
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

5.  Autoimmune mechanisms of scleroderma and a role of oxidative stress.

Authors:  Toshiyuki Yamamoto
Journal:  Self Nonself       Date:  2011-01-01

6.  Engineering an "infectious" T(reg) biomimetic through chemoselective tethering of TGF-β1 to PEG brush surfaces.

Authors:  E Y Yang; J P Kronenfeld; K M Gattás-Asfura; A L Bayer; C L Stabler
Journal:  Biomaterials       Date:  2015-07-14       Impact factor: 12.479

Review 7.  Scleroderma-like cutaneous syndromes.

Authors:  Yasuji Mori; Veli-Matti Kahari; John Varga
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

8.  Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masahide Kubo; Kunihiko Tamaki
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

9.  Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.

Authors:  Masahide Kubo; Joanna Czuwara-Ladykowska; Omar Moussa; Margaret Markiewicz; Edwin Smith; Richard M Silver; Stefania Jablonska; Maria Blaszczyk; Dennis K Watson; Maria Trojanowska
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.

Authors:  Xiao-Yong Man; Kenneth W Finnson; Murray Baron; Anie Philip
Journal:  Arthritis Res Ther       Date:  2012-06-13       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.